Health Disparities and Cancer: Racial Disparities in Cancer Mortality in the United States, 2000–2010

Frontiers in Public Health

Volumn 3, Issue , 2015, Pages

  O’Keefe, Eileen B ^a   Meltzer, Jeremy P ^a   Bethea, Traci N ^b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

affordable care act; cancer mortality; disparities; race ethnicity; socioeconomic status

Indexed keywords

EID: 85118967897     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2015.00051     Document Type: Review

References (114)

1. Byers T. Two decades of declining cancer mortality: progress with disparity. Annu Rev Public Health (2010) 31:121–32.10.1146/annurev.publhealth.121208.13104720070204
2. DeSantis C Naishadham D Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 63(3):151–66.10.3322/caac.2117323386565
3. Marmot MG Stansfeld S Patel C North F Head J White I et al. Health inequalities among British civil servants: the Whitehall II study. Lancet (1991) 337:1387–93.10.1016/0140-6736(91)93068-K1674771
4. Marmot M. Social determinants of health inequalities. Lancet (2005) 365:1099–104.10.1016/S0140-6736(05)74234-3
5. Singh GK Miller BA Hankey BF Edwards BK. Area Socioeconomic Variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD: National Cancer Institute (2003). NIH Publication No. 03-5417.
6. Ward E Jemal A Cokkindes V Singh GK Cardinez C Gharfoor A et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 54:78–93.10.3322/canjclin.54.2.7815061598
7. st century: an ecosocial perspective. Int J Epidemiol (2001) 30:668–77.10.1093/ije/30.4.668
8. Krieger N Chen JT Waterman PD Soobader M Subramanian SV Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: dose the choice of area-based measure and geographic level matter? The public health disparities geocoding project. Am J Epidemiol (2002) 156:471–82.10.1093/aje/kwf068
9. Krieger N. Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control (2005) 16:5–14.10.1007/s10552-004-1251-515750853
10. Quaglia A Lillini R Mamo C Ivaldi E Vercelli M. Socio-economic inequalities: a review of methodological issues and the relationships with cancer survival. Crit Rev Oncol Hematol (2013) 85:266–77.10.1016/j.critrevonc.2012.08.00722999326
11. U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington DC: US Government Printing Office (2000).
12. U.S Department of Health and Human Services. Healthy People 2020: Disparities. Washington DC: US Government Printing Office (2010). Available from: http://www.healthypeople.gov/2020/about/disparitiesAbout.aspx
13. World Health Organization. Social Determinants of Health (2014). Available from: http://www.who.int/topics/social_determinants/en/
14. David R Collins J Jr. Disparities in infant mortality: what’s genetics got to do with it? Am J Public Health (2007) 97(7):1191–7.10.2105/AJPH.2005.06838717538073
15. Hebert PL Sisk JE Howell EA. When does a difference become a disparity? Conceptualizing racial and ethnic disparities in health. Health Aff (2008) 27(2):374–82.10.1377/hlthaff.27.2.37418332492
16. Donnelly DW Gavin A. Socio-economic inequalities in cancer incidence – the choice of deprivation measure matters. Cancer Epidemiol (2011) 35(b):e55–61.10.1016/j.canep.2011.06.00221840786
17. Woods LM Rachet B Coleman MP. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer (2005) 92(7):1279–82.10.1038/sj.bjc.660250615798765
18. Robert SA Strombom I Trentham-Dietz A Hampton JM McElroy JA Newcomb PA et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology (2004) 15(4):442–50.10.1097/01.ede.0000129512.61698.0315232405
19. Krieger N Chen JT Waterman PD Rehkopf DH Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures – the public health disparities geocoding project. Am J Public Health (2003) 93(10):1655–71.10.2105/AJPH.93.10.165514534218
20. Iceland J Weinberg DH Steinmetz EUS. Census Bureau: Racial and Ethnic Segregation in the United States. Washington, DC: US Government Printing Office (2002).
21. Iceland J Sharpe C Steinmetz E. Class differences in African American residential patterns in US metropolitan areas: 1990-2000. Soc Sci Res (2005) 34:252–66.10.1016/j.ssresearch.2004.02.001
22. Williams DR Jackson PB. Social sources of racial disparities in health. Health Aff (Millwood) (2005) 24:325–34.10.1377/hlthaff.24.2.32515757915
23. Sharkey P. Spatial segmentation and the black middle class. AJS (2014) 119:903–54.10.1086/67456125032266
24. Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann N Y Acad Sci (1999) 896:173–88.10.1111/j.1749-6632.1999.tb08114.x10681897
25. Robert SA. Socioeconomic position and health: The independent contribution of community socioeconomic context. Annu Rev Soc (1999) 25:489–516.10.1146/annurev.soc.25.1.489
26. Morland K Filomena S. Disparities in the availability of fruits and vegetables between racially segregated urban neighbourhoods. Public Health Nutr (2007) 10(12):1481–9.10.1017/S136898000700007917582241
27. Moore LV Diez Roux AV Evenson KR McGinn AP Brines SJ. Availability of recreational resources in minority and low socioeconomic status areas. Am J Prev Med (2008) 34(1):16–22.10.1016/j.amepre.2007.09.02118083446
28. Powell LM Slater S Chaloupka FJ Harper D. Availability of physical activity-related facilities and neighborhood demographic and socioeconomic characteristics: a national study. Am J Public Health (2006) 96(9):1676–80.10.2105/AJPH.2005.06557316873753
29. Massey DS Fischer MJ. How segregation concentrates poverty. Ethn Racial Stud (2000) 23(4):670–91.10.1080/0141987005003367611037206
30. Hayanga AJ Zeliadt SB Backlus LM. Residential segregation and lung cancer mortality in the United States. JAMA Surg (2013) 48(1):37–42.10.1001/jamasurgery.2013.40823324839
31. Haas JS Earle CC Orav JE Brawarsky P Keohane M Neville BA et al. Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 113(8):2166–72.10.1002/cncr.2382818798230
32. Dai D. Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place (2010) 16(5):1038–52.10.1016/j.healthplace.2010.06.01220630792
33. Russell EF Kramer MR Cooper HL Gabram-Mendola S Senior-Crosby D Jacob Arriola KR. Metropolitan area racial residential segregation, neighborhood racial composition, and breast cancer mortality. Cancer Causes Control (2012) 23(9):1519–27.10.1007/s10552-012-0029-422825071
34. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stata Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov. 2013 Sub (2000-2011) -Linked to County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch (2014).
35. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Mortality – All COD, Aggregated With State Total US (1969-2010) . Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch (2013). Released April 2013; underlying mortality data provided by National Center for Health Statistics 2013.
36. Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged >18 years – United States, 2005-2010. MMWR Morb Mortal Wkly Rep (2011) 60(35):1207–12.21900875
37. Siegel R Naishadham D Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 62:283–98.10.3322/caac.2115322987332
38. Jemal A Center MM Ward E. The convergence of lung cancer rates between blacks and whites under the age of 40, United States. Cancer Epidemiol Biomarkers Prev (2009) 18:3349–52.10.1158/1055-9965.EPI-09-074019959681
39. Houston KA Henley J Li J White MC Richard TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009. Lung Cancer (2014) 86(1):22–8.10.1016/j.lungcan.2014.08.00125172266
40. Riaz SP Lüchtenborg M Coupland VH Spicer J Peake MD Møller H. Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer (2012) 75:280–4.10.1016/j.lungcan.2011.08.00421893364
41. Govindan R Page N Morgensztern D Read W Tierney R Vlahiotis A et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol (2006) 24(28):4539–44.10.1200/JCO.2005.04.485917008692
42. Grenade C Phelps MA Villalona-Calero MA. Race and ethnicity in cancer therapy: what have we learned? Clin Pharmacol Ther (2014) 95(4):403–12.10.1038/clpt.2014.524419564
43. Lathan CS Neville BA Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol (2006) 24(3):413–8.10.1200/JCO.2005.02.175816365180
44. Blackstock AW Herndon JE Paskett ED Perry MC Graziano SL Muscato JJ et al. Outcomes among African-American/Non-African-American patients with advanced non-small-cell lung carcinoma: report from the cancer and leukemia group B. J Natl Cancer Inst (2002) 94(4):284–90.10.1093/jnci/94.4.28411854390
45. Zheng L Enewold L Zahm SH Shriver CD Zhou J Marrogi A et al. Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol Biomarkers Prev (2012) 21:1841–7.10.1158/1055-9965.EPI-12-056022899731
46. The Henry J. Kaiser Family Foundation. Poverty Rate By Race/Ethnicity (2014). Available from: http://kff.org/other/state-indicator/poverty-rate-by-raceethnicity/
47. DeSantis C Ma J Bryan L Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin (2014) 64(1):52–62.10.3322/caac.21203
48. Rossouw JE Manson JE Kaunitz AM Anderson GL. Lessons learned from the Women’s Health Initiative trials of menopausal hormone therapy. Obstet Gynecol (2013) 121(1):172–6.10.1097/AOG.0b013e31827a08c823262943
49. Berry DA Cronin KA Plevritis SK Fryback DG Clarke L Zelen M et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 353(17):1784–92.10.1056/NEJMoa05051816251534
50. Wray CJ Phatak UR Robinson EK Wiatek RL Rieber AG Gonzalez A et al. The effect of age-related breast cancer survival disparities. Ann Surg Oncol (2013) 20(8):2541–7.10.1245/s10434-013-2913-x23435633
51. Maskarinec G Sen C Koga K Conroy SM. Ethnic differences in breast cancer survival: status and determinants. Womens Health (Lond Engl) (2011) 7(6):677–87.10.2217/whe.11.6722040209
52. Ooi SL Martinez ME Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat (2011) 127(3):729–38.10.1007/s10549-010-1191-621076864
53. Albain KS Unger JM Crowley JJ Coltman CA Jr Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst (2009) 101(14):984–92.10.1093/jnci/djp17519584328
54. Tannenbaum SL Koru-Sengul T Miao F Byrne MM. Disparities in survival after female breast cancer diagnosis: a population-based study. Cancer Causes Control (2013) 24(9):1705–15.10.1007/s10552-013-0246-523775026
55. Sheppard VB Isaacs C Luta G Willey SC Boisvert M Harper FWK et al. Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship. Breast Cancer Res Treat (2013) 139(1):207–16.10.1007/s10549-013-2520-323588954
56. Mandelblatt JS Sheppard VB Neugut AI. Black-white differences in breast cancer outcomes among older Medicare beneficiaries: does systemic treatment matter? JAMA (2013) 310(4):376–7.10.1001/jama.2013.8273
57. Rizzo M Lund MJ Mosunjac M Bumpers H Holmes L O’Regan R et al. Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer. Cancer (2009) 115(13):3009–15.10.1002/cncr.2433419466698
58. Danforth DN Jr. Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res (2013) 15(3):208.10.1186/bcr342923826992
59. Parise CA Caggiano V. Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers. J Cancer Epidemiol (2014) 2014:469251.10.1155/2014/46925124955090
60. Lund MJ Trivers KF Porter PL Coates RJ Leyland-Jones B Brawley OW et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat (2009) 113(2):357–70.10.1007/s10549-008-9926-318324472
61. Banegas MP Tao L Altekruse S Anderson WF John EM Clarke CA et al. Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California. Breast Cancer Res Treat (2014) 144(3):625–34.10.1007/s10549-014-2882-124658879
62. Bauer KR Brown M Cress RD Parise CA Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer; the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer (2007) 109(9):1721–8.10.1002/cncr.2261817387718
63. Dunn BK Agurs-Collins T Browne D Lubet R Johnson KA. Health disparities in breast cancer: biology meets socioeconomic status. Breast Cancer Res Treat (2010) 121(2):281–92.10.1007/s10549-010-0827-x20437200
64. Hudis CA Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist (2011) 16(1):1–11.10.1634/theoncologist.2011-S1-01
65. Trivers KF Lund MJ Porter PL Liff JM Flagg EW Coates RJ et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control (2009) 20(7):1071–82.10.1007/s10552-009-9331-119343511
66. Boone SD Baumgartner KB Joste NE Pinkston CM Yang D Baumgartner RN. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women. Cancer Causes Control (2014) 25(3):273–82.10.1007/s10552-013-0329-324337810
67. Abdel-Maksoud MF Risendal BC Slattery ML Giuliano AR Baumgartner KB Byers TE. Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Res Treat (2001) 131(1):169–76.10.1007/s10549-011-1705-x21822637
68. Hines LM Risendal B Byers T Mengshol S Lowery J Singh M. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Womens Health (Larchmt) (2011) 20(10):1543–50.10.1089/jwh.2010.255821721934
69. Shariff-Marco S Yang J John EM Sangaramoorthy M Hertz A Koo J et al. Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the neighborhood and breast cancer study. Cancer Epidemiol Biomarkers Prev (2014) 23(5):793–811.10.1158/1055-9965.EPI-13-092424618999
70. Sprague BL Trentham-Dietz A Gangnon RE Ramchandani R Hampton JM Robert SA et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer (2011) 117(7):1542–51.10.1002/cncr.2558921425155
71. Andaya AA Enewold L Horner MJ Jatoi I Shriver CD Zhu K. Socioeconomic disparities and breast cancer hormone receptor status. Cancer Causes Control (2012) 23(6):951–8.10.1007/s10552-012-9966-1
72. Herndon JE II Kornblith AB Holland JC Paskett ED. Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials. Psychooncology (2013) 22(2):315–23.10.1002/pon.209422021121
73. Albano JD Ward E Jemal A Anderson R Cokkinides VE Murray T et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 99(18):1384–94.10.1093/jnci/djm12717848670
74. Parise CA Caggiano V. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California cancer registry, 2000-2010. BMC Cancer (2013) 13:449.10.1186/1471-2407-13-44924083624
75. Gordon NH. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev (2003) 22(1):55–65.10.1023/A:102221201815812716037
76. Echeverria SE Borrell LN Brown D Rhoads G. A local area analysis of racial, ethnic, and neighborhood disparities in breast cancer staging. Cancer Epidemiol Biomarkers Prev (2009) 18(11):3024–9.10.1158/1055-9965.EPI-09-039019843685
77. Clegg LX Reichman ME Miller BA Hankey BF Singh GK Lin YD et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national longitudinal mortality study. Cancer Causes Control (2009) 20(4):417–35.10.1007/s10552-008-9256-019002764
78. Rauscher GH Wiley EL Campbell RT. Socioeconomic disadvantage predicts more aggressive estrogen/progesterone receptor negative breast cancer and mediates racial and ethnic disparities in breast cancer aggressiveness. Cancer Epidemiol Biomarkers Prev (2012) 21(10):B39.10.1158/1055-9965.DISP12-B39
79. Vona-Davis L Rose DP. The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt) (2009) 18(6):883–93.10.1089/jwh.2008.112719514831
80. Thompson IM Goodman PJ Tangen CM Lucia MS Miller GJ Ford LG et al. The influence of finasteride on the development of prostate cancer. N Engl J Med (2003) 349(3):215–24.10.1056/NEJMoa03066012824459
81. Siegel R Ma J Zou Z Jemal A. Cancer statistics, 2014. CA Cancer J Clin (2014) 64(1):9–29.10.3322/caac.21208
82. Taksler GB Keating NL Cutler DM. Explaining racial differences in prostate cancer mortality. Cancer (2012) 118:4280–9.10.1002/cncr.2737922246942
83. Moses KA Paciorek AT Penson DF Carroll PR Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol (2010) 28(6):1069–74.10.1200/JCO.2009.26.246920100957
84. Bill-Axelson A Holmberg L Ruutu M Garmo H Stark JR Busch C. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 364(18):1708–17.10.1056/NEJMoa101196721542742
85. Kibel AS Ciezki JP Klein EA Reddy CA Lubahn JD Haslag-Minoff J et al. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol (2012) 187:1259–65.10.1016/j.juro.2011.11.08422335870
86. Chornokur G Dalton K Borysova ME Kumar NB. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate (2011) 71:985–97.10.1002/pros.2131421541975
87. Major JM Oliver MN Doubeni CA Hollenbeck AR Graubard BI Sinha R. Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study. Cancer Causes Control (2012) 23:1185–91.10.1007/s10552-012-9988-8
88. Berglund A Holmberg L Garmo H Bratt O Robinson D Adolfsson J et al. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer Prev (2012) 48:75–84.10.1016/j.ejca.2011.07.00921852113
89. Dimou A Syrigos KN Saif MW. Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis. World J Gastroenterol (2009) 15(30):3734–43.10.3748/wjg.15.373419673013
90. Matanoski G Tao X Almon L Adade AA Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer (2006) 107(5):1112–20.10.1002/cncr.22008
91. Shipp MPL Desmond R Accortt N Wilson RJ Fouad M Eloubeidi MA. Population-based study of the geographic variation in colon cancer incidence in Alabama: relationship to socioeconomic status indicators and physician density. South Med J (2005) 98:1076–82.10.1097/01.smj.0000184844.01148.1016353380
92. Rabeneck L Souchek J El-Serag HB. Survival of colorectal cancer patients hospitalized in the veterans affairs health care system. Am J Gastroenterol (2003) 98(5):1186–92.10.1111/j.1572-0241.2003.07448.x12809847
93. White A Vernon SW Franzini L Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics. Cancer (2010) 116:4622–31.10.1002/cncr.2539520626015
94. Lansdorp-Vogelaar I Kuntz KM Knudsen AB van Ballegooijen M Zauber AG Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 21(5):728–36.10.1158/1055-9965.EPI-12-002322514249
95. Bach PB Schrag D Brawley OW Galaznik A Yakren S Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA (2002) 287(16):2106–13.10.1001/jama.287.16.210611966385
96. Du XL Meyer TE Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer (2007) 109:2161–70.10.1002/cncr.2266417455219
97. Du XL Fang S Vernon SW El-Serag H Shih YT Davila J et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer (2007) 110:660–9.10.1002/cncr.2282617582625
98. Gomez SL O’Malley CD Stroup A Shema SJ Satariano WA. Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity. BMC Cancer (2007) 7:1.10.1186/1471-2407-7-117939875
99. Blumenthal D Collins SR. Health care coverage under the affordable care act – a progress report. N Engl J Med (2014) 371(3):275–81.10.1056/NEJMhpr1405667
100. Centers for Disease Control and Prevention. Prevalence of colorectal cancer screening among adults – Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 61(2):51–6.22695464
101. Patient-Centered Outcomes Research Institute: Mission and Vision. Available from: http://www.pcori.org/about-us/mission-and-vision/
102. Patient-Centered Outcomes Research Institute. Addressing Disparities Program Advisory Panel: April 2014 Meeting Summary. Washington, DC (2014).
103. Markowitz LE Hariri S Lin C Dunne EF Steinau M McQuillan G et al. Reduction in Human Papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis (2013) 208(3):385–93.10.1093/infdis/jit19223785124
104. Lehtinen M Paavonen J Wheeler CM Jaisamrarn U Garland SM Castellsague X et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomized, double-blind PATRICIA trial. Lancet Oncol (2012) 13:89–99.10.1016/S1470-2045(11)70286-822075171
105. Hildesheim A Wacholder S Catteau G Struyf F Dubin G Herrero R. Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial. Vaccine (2014) 32:5087–97.10.1016/j.vaccine.2014.06.03825018097
106. Rana MM Huhtala H Apter D Eriksson T Luostarinen T Natunen K et al. Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: cancer registry-based follow-up. Int J Cancer (2013) 132:2833–8.10.1002/ijc.2797123180157
107. Lee SJ Boscardin WJ Stijacic-Cenzer I Conell-Price J O’Brien S Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ (2012) 345:1–9.10.1136/bmj.e844123299842
108. Whitlock EP Lin JS Liles E Beil TL Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. preventive services task force. Ann Intern Med (2008) 149:638–58.10.7326/0003-4819-149-9-200811040-0024518838718
109. Klabunde C Cronin KA Breen N. Trends in colorectal cancer test use among vulnerable populations in the U.S. Cancer Epidemiol Biomarkers Prev (2011) 20(8):1611–21.10.1158/1055-9965.EPI-11-022021653643
110. Koh HK Sebelius KG. Promoting prevention through the Affordable Care Act. N Engl J Med (2010) 363(14):1296–9.10.1056/NEJMp10085602087987
111. Ku L Levy A Lantz P Pierre-Matthieu R. Options for CDC’s Cancer Screening Programs: Implications of the Affordable Care Act. Washington, DC: Department of Health Policy, School of Public Health and Health Services, The George Washington University (2011). p. 1–12.
112. Centers for Disease Control and Prevention. Cancer screening – United States, 2010. MMWR Morb Mortal Wkly Rep (2012) 61(3):41–5.
113. Moy B Polite BN Halpern MT Stranne SK Winer EP Wollins DS et al. American society of clinical oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol (2011) 29(28):3816–24.10.1200/JCO.2011.35.890321810680
114. American Cancer Society. Cancer Facts & Figures 2014. Atlanta, GA: American Cancer Society (2014).